ELISA Kit for Atrial Natriuretic Peptide (ANP)

ANH; ANF; CDD; Atrial Natriuretic Factor; Atrial Natriuretic Hormone; Atriopeptin; Cardionatrine; Cardiodilatin

FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
  • ELISA Kit for Atrial Natriuretic Peptide (ANP)Packages (Simulation)
  • ELISA Kit for Atrial Natriuretic Peptide (ANP)Packages (Simulation)
  • ELISA Kit for Atrial Natriuretic Peptide (ANP)Results demonstration
  • CEA225Ca.jpgTypical Standard Curve
  • CertificateISO9001: 2008, ISO13485: 2003 Registered

Specificity

This assay has high sensitivity and excellent specificity for detection of Atrial Natriuretic Peptide (ANP).
No significant cross-reactivity or interference between Atrial Natriuretic Peptide (ANP) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Atrial Natriuretic Peptide (ANP) and the recovery rates were calculated by comparing the measured value to the expected amount of Atrial Natriuretic Peptide (ANP) in samples.

MatrixRecovery range (%)Average(%)
serum(n=5)80-8885
EDTA plasma(n=5)88-10398
heparin plasma(n=5)84-10393

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Atrial Natriuretic Peptide (ANP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Atrial Natriuretic Peptide (ANP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Atrial Natriuretic Peptide (ANP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample1:21:41:81:16
serum(n=5)88-96%98-105%88-95%95-102%
EDTA plasma(n=5)93-105%78-97%79-90%92-104%
heparin plasma(n=5)96-105%93-103%81-102%85-94%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

ReagentsQuantityReagentsQuantity
Pre-coated, ready to use 96-well strip plate1Plate sealer for 96 wells4
Standard2Standard Diluent1×20mL
Detection Reagent A1×120µLAssay Diluent A1×12mL
Detection Reagent B1×120µLAssay Diluent B1×12mL
TMB Substrate1×9mLStop Solution1×6mL
Wash Buffer (30 × concentrate)1×20mLInstruction manual1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

ELISA Kit for Atrial Natriuretic Peptide (ANP)

Test principle

This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Atrial Natriuretic Peptide (ANP) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Atrial Natriuretic Peptide (ANP) and unlabeled Atrial Natriuretic Peptide (ANP) (Standards or samples) with the pre-coated antibody specific to Atrial Natriuretic Peptide (ANP). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Atrial Natriuretic Peptide (ANP) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Atrial Natriuretic Peptide (ANP) in the sample.

Related products

Catalog No.Organism species: Canis familiaris; Canine (Dog)Applications
RPA225Ca01Recombinant Atrial Natriuretic Peptide (ANP)Positive Control; Immunogen; SDS-PAGE; WB.
CPA225Ca21OVA Conjugated Atrial Natriuretic Peptide (ANP)Immunogen; SDS-PAGE; WB.
PAA225Ca01Polyclonal Antibody to Atrial Natriuretic Peptide (ANP)WB; IHC; ICC; IP.
PAA225Ca08Polyclonal Antibody to Atrial Natriuretic Peptide (ANP)WB; IHC; ICC; IP.
MAA225Ca21Monoclonal Antibody to Atrial Natriuretic Peptide (ANP)WB; IHC; ICC; IP.
CEA225CaELISA Kit for Atrial Natriuretic Peptide (ANP)Enzyme-linked immunosorbent assay for Antigen Detection.
GUESTBOOK